Results 251 to 260 of about 144,401 (340)

Characteristics of 24-h ambulatory blood pressure monitoring in elderly hypertensive males: An observational study of 85 year older patients. [PDF]

J Clin Hypertens (Greenwich)
Wang J, Xiao P, Ye Y, Chen X, Hu X, Yang Y, Peng Y.   +6 more
europepmc   +1 more source

Impact of a Care Pathway for Older Patients Undergoing Emergency Abdominal Surgery: A Before‐and‐After Study

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 2, February 2026.
ABSTRACT Background Older patients undergoing emergency abdominal surgery face high risks of mortality and complications. Objective Investigate whether a care pathway designed for older patients improves surgical outcomes. Methods This single‐centre study investigated the effect of a care pathway for older patients undergoing emergency abdominal ...
Elin Kismul Aakre, Bjørn Steinar Olden Nedrebø, Atle Ulvik, Anette Hylen Ranhoff, Hans Flaatten, Karl Ove Hufthammer, Ib Jammer   +6 more
wiley   +1 more source

Twenty-four Hour Ambulatory Blood Pressure Monitoring in Open Angle Glaucoma Suspects: A cross-sectional descriptive study. [PDF]

Rom J Ophthalmol
Bharathi M, Kaliaperumal S, Selvarajan S, Srinivasan R, Stephen M.   +4 more
europepmc   +1 more source

Pharmacological intervention: Challenges and promising outcomes for fat loss and preservation of lean body mass in the treatment of overweight and type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 803-816, February 2026.
Abstract Treatment with GLP‐1 receptor agonists (GLP‐1 RAs) is effective in reducing body weight in individuals with overweight and type 2 diabetes (T2D). However, measurements indicate that a considerable portion of the weight loss derives from fat‐free mass (FFM), including skeletal muscle, which may compromise metabolic health and physical function.
Viktor Aimelet, Jens Juul Holst
wiley   +1 more source

Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride‐glucose index

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 982-993, February 2026.
Abstract Background and Aims Triglyceride‐glucose (TyG) index, is an emerging prognostic biomarker in atherosclerotic cardiovascular disease (ASCVD). Validation of its clinical value and of clinically relevant prognostic cut‐off, remains an unmet need to integrate TyG into primary prevention protocols.
Georgios Mavraganis, Georgios Georgiopoulos, Stavros Athanasopoulos, Dimitrios Terentes‐Printzios, Georgios Zervas, Christina Konstantaki, Maria Eleni Koilakou, Sofia‐Panagiota Giannakopoulou, Maria‐Angeliki Dimopoulou, Christina Chrysochoou, Konstantinos Tsioufis, Christos Pitsavos, Evangelos Liberopoulos, Konstantinos Stellos, Charalambos Vlachopoulos, Demosthenes Panagiotakos, Kimon Stamatelopoulos   +16 more
wiley   +1 more source

Safety and efficacy of the therapy with CD4 + CD25highCD127‐T regulatory cells: When paediatric patient becomes adult

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1392-1402, February 2026.
Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura, Magdalena Piotrowska‐Mieczkowska, Matylda Hennig, Mateusz Gliwiński, Anna Wołoszyn‐Durkiewicz, Julia Schoenhoff, Milena Dybowska, Anna Alska, Piotr Gutknecht, Bartosz Trzeciak, Katarzyna Stefańska, Paulina Glasner, Marcin Hellmann, Jacek Burzyński, Arkadiusz Michalak, Janusz Siebert, Dorota Iwaszkiewicz‐Grześ, Małgorzata Myśliwiec, Piotr Trzonkowski   +18 more
wiley   +1 more source

Relationship of 24-Hour Mean Arterial Pressure with Systolic and Diastolic Blood Pressure in Hypertension: Insights from Ambulatory Blood Pressure Monitoring. [PDF]

Anatol J Cardiol
Karahan A, Zor U.
europepmc   +1 more source

Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy

European Journal of Haematology, Volume 116, Issue 2, Page 104-115, February 2026.
ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley   +1 more source

Ambulatory Blood Pressure Monitoring

Korean Circulation Journal, 1991
openaire   +1 more source

Race differences in ambulatory blood pressure monitoring parameters. [PDF]

Blood Press Monit
Sakhuja S, Jaeger BC, Yano Y, Shimbo D, Lewis CE, Clark Iii D, Tajeu GS, Hardy ST, Allen NB, Shikany JM, Schwartz JE, Viera AJ, Muntner P.   +12 more
europepmc   +1 more source